4 min read
ASCO 2026: RAS Is No Longer Undruggable
For decades, oncologists and drug developers shared an undeniable truth: KRAS – one of the most commonly mutated genes...
June 22-25, 2026 – San Diego, CA
🌎 Bringing the Global Biopharma Community Together
We’re delighted to be attending the BIO International Convention, where biotech leaders, investors, and partners come together to advance the next generation of therapies. As programs move through early and mid-stage development, success increasingly depends on disciplined planning, high-quality evidence, and regulatory alignment across regions.
We’re looking forward to meeting sponsors and innovators to talk through how programs are actually progressing, and where the pressure points are showing up. Veristat supports that work with integrated regulatory, clinical, and biostatistical expertise, built to help teams use development capital wisely and move forward with stronger decisions.
👥 Meet with Us at Bio International Convention 2026
Connect with us at the event to explore how Veristat’s scientific leadership and focused capabilities can help advance your clinical and regulatory milestones.
Complete the form on this page to reserve time with our team. We welcome the opportunity to learn about your upcoming programs and explore how Veristat can support your development strategy.
ℹ️ About Veristat
Whether you're launching a first-in-human study or navigating complex regulatory pathways, Veristat delivers integrated expertise and personalized support across the development lifecycle:
- Full-Service Clinical Development Solutions
- Clinical Operations Excellence
- Global Regulatory Strategy & Submissions
For more than 30 years, Veristat has partnered with emerging and established biopharmaceutical companies to navigate development challenges with scientific expertise, operational excellence, and a collaborative approach. From early development through commercialization, our teams deliver tailored strategies designed to accelerate progress and support successful outcomes for life-changing therapies.
Let’s connect and discuss where your program is headed.
Schedule A Meeting
Meet with us at the Bio International Convention 2026
San Diego, CA | June 22 - 25
10 min read
Monthly FDA Guidance and Regulatory News Review - May 2026
Jun 12, 2026 Veristat Blog
This May 2026 regulatory update highlights multiple guidances issued by the FDA across cell and gene therapy, clinical...